RET Inhibitors

RET inhibitors are specialized medications designed to block the activity of the RET gene, which can promote cancer growth when mutated or overactive. These drugs target the RET proteins that send signals encouraging tumor cells to grow and divide. By inhibiting RET, these medicines can slow or stop the progression of certain cancers, such as thyroid and lung cancers. They represent a targeted approach in cancer therapy, aiming to attack cancer cells specifically without harming normal cells, thereby improving treatment effectiveness and reducing side effects.